Covered recipient · General Payments record
EDWIN CHIU
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2020–2024
$685.01
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.38 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TAIHO ONCOLOGY, INC. | $38.71 | 2 |
| ARRAY BIOPHARMA INC | $32.71 | 2 |
| Astellas Pharma US Inc | $29.48 | 2 |
| Agios Pharmaceuticals, Inc. | $25.27 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $24.19 | 1 |
| Celgene Corporation | $21.16 | 1 |
| Genentech USA, Inc. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $25.27 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149645065 | CMS |
| ARRAY BIOPHARMA INC | $16.69 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131192439 | CMS |
| ARRAY BIOPHARMA INC | $16.02 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131397383 | CMS |
| Astellas Pharma US Inc | $13.27 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139296320 | CMS |
| Astellas Pharma US Inc | $16.21 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369731 | CMS |
| Celgene Corporation | $21.16 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101092939 | CMS |
| Genentech USA, Inc. | $13.86 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133005322 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $24.19 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139161856 | CMS |
| TAIHO ONCOLOGY, INC. | $20.04 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137933793 | CMS |
| TAIHO ONCOLOGY, INC. | $18.67 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137939896 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.